US FDA Reorg: Defining The “Central” Purpose Of A Commissioner
Executive Summary
Scott Gottlieb will formally implement a new structure for the Office of the Commissioner just days before he departs from the job. That may be odd timing, but the new structure is in many ways a perfect capstone for Gottlieb’s tenure.
You may also be interested in...
US FDA Succession Question Looms For Biden Administration As Hahn Departure Nears
As is tradition, political appointments offer resignations when a new administration takes office. The incoming president can ask them to stay but often they are let go. Commissioner Hahn is expected to be among the many Trump administration agency heads who will depart.
US FDA Faces Succession Questions As Hahn’s Departure Nears
Plan specifying the acting head of FDA until new commissioner is confirmed references senior positions that no longer exist.
Oncology Center of Excellence Grows Leadership Structure, With A Vacancy Remaining
A deputy center director position remains open and four new associate director positions were added over the last year.